Generic EGFR Inhibitor for NSCLC

Dacomitinib’s job is to block the Epidermal Growth Factor Receptor, which is key in treating a type of lung cancer we call Non-Small Cell Lung Cancer. This medicine goes after particular changes in the EGFR gene, like when there’s a chunk missing in exon 19 or a certain switch is flipped at L858R in exon 21. You can get Dacomitinib in three strengths — 15, 30, and 45 milligrams.

Most people take the middle one, 45 mg, every day. The pills have a coating to protect them and come in bottles with 30 pills in each.